Enable JavaScript to visit this website.

Utility Menu

EUCRISA-4-You Savings and Support logo 1

We're here to help!

eucrisa•4•you is a savings and support program* designed to help you.

Eucrisa 4 you

Savings for eligible patients

Pay as little as $10 with the EUCRISA® (crisaborole) copay savings card, eligibility required 1

Want to save on EUCRISA?*

Eligible patients pay as little as:

$
10

Patients with commercial insurance
that covers EUCRISA*

*Eligibility required. Savings up to $970 per tube. Annual savings up to $3,880.
State and federal beneficiaries not eligible. Terms and conditions apply.

Get your EUCRISA Copay Savings Card now

Get a Card via Text Download a Card

Message and data rates may apply.

You may also call 1-866-EUCRISA (1-866-382-7472) to request your Copay Savings Card, or ask your doctor.

Personalized support to help you with your Insurance for EUCRISA

If you have a EUCRISA prescription and need help understanding your insurance coverage for EUCRISA, follow the instructions below:

Call

1-844-EUCRISA

(1-844-382-7472)
Representatives are available

8 AM - 8 PM ET

Monday through Friday
Download Insurance Support FAQs

EUCRISA Information Sign Up

Sign up

for the eucrisa•4•you Savings and Support Program. You will receive a welcome letter and periodic communications with helpful information about EUCRISA.

Sign Up for eucrisa•4•you
Important Safety Information & Indication
 

IMPORTANT SAFETY INFORMATION

Do not use EUCRISA if you are allergic to crisaborole or any of the ingredients in EUCRISA.

EUCRISA may cause side effects including allergic reactions at or near the application site. These can be serious and may include hives, itching, swelling, and redness. If you have any of these symptoms, stop using EUCRISA and get medical help right away.

The most common side effect of EUCRISA is application site pain, such as burning or stinging.

EUCRISA is for use on skin (topical use) only. Do not use EUCRISA in your eyes, mouth, or vagina.

INDICATION
EUCRISA is a prescription ointment used on the skin (topical) to treat mild-to-moderate eczema (atopic dermatitis) in adults and children 2 years of age and older.

See Full Prescribing Information .

Exit Link PopUp

You are now leaving EUCRISA.com
Links to external websites are provided as a convenience to the viewer. Pfizer accepts no responsibility for the content of linked sites.
Continue
Stay on this site >
TERMS AND CONDITIONS

EUCRISA® (crisaborole) ointment, 2%
Copay Savings Card

By using the EUCRISA Copay Savings Card (the "Card"), you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions.

  • Patients are not eligible to use this card if they are enrolled in a state or federally funded prescription insurance program, including Medicare Part D, Medicaid, TRICARE, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as “La Reforma de Salud”). If you are enrolled in a state or federally funded prescription insurance program, you may not use this savings card even if you elect to be processed as an uninsured (cash-paying) patient.
  • This Card is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your commercial insurance plan or any other health or pharmacy benefit program.
  • By using this Card at participating pharmacies, eligible patients with commercial prescription drug insurance coverage for EUCRISA may pay as little as $10 per tube. Eligible patients with commercial prescription drug insurance coverage that does not cover EUCRISA may pay as little as $70 per tube. Eligible patients without prescription drug insurance who pay cash may pay as little as $100 per tube. Individual savings are limited to $970 per tube. Individual patient savings are limited to $3,880 in maximum total savings per calendar year.
  • You must deduct the value of the savings that you receive from this Card from any reimbursement request submitted to your commercial insurance plan, either directly by you or on your behalf.
  • You are responsible for reporting receipt of any savings from the Card to any commercial insurer, health plan, or other third party that pays for or reimburses any part of the cost of the prescription filled using the Card, as may be required by such insurer or plan. You should not use the Card if your insurer or health plan prohibits use of manufacturer copay cards.
  • This copay program is not valid where prohibited by law.
  • The Card cannot be combined with any other rebate/copay program, free trial or similar offer for the specified prescription.
  • The Card will be accepted only at participating pharmacies.
  • This Card is not health insurance.
  • Offer good only in the U.S. and Puerto Rico.
  • The Card is limited to 1 per person during this offer period and is not transferable.
  • The Card may not be redeemed more than once per 30 days per patient.
  • No other purchase is necessary.
  • Data related to your redemption of the Card may be collected, analyzed, and shared with Pfizer, for market research and other purposes related to assessing Pfizer’s programs. Data shared with Pfizer will be aggregated and de-identified; it will be combined with data related to other Card redemptions and will not identify you.
  • Pfizer reserves the right to rescind, revoke or amend this offer at any time without notice.
  • No membership fees.
  • Offer expires 03/31/20.

If you have questions or are in need of additional support, call 1-877-548-1739. Pfizer Inc, PO Box 29387, Mission, KS 66201.

Important Safety Information & Indication
 

IMPORTANT SAFETY INFORMATION

IMPORTANT SAFETY INFORMATION AND INDICATION

Do not use EUCRISA if you are allergic to crisaborole or any of the ingredients in EUCRISA.

EUCRISA may cause side effects including allergic reactions at or near the application site. These can be serious and may include hives, itching, swelling, and redness. If you have any of these symptoms, stop using EUCRISA and get medical help right away.

The most common side effect of EUCRISA is application site pain, such as burning or stinging.

EUCRISA is for use on skin (topical use) only. Do not use EUCRISA in your eyes, mouth, or vagina.

INDICATIONEUCRISA is a prescription ointment used on the skin (topical) to treat mild-to-moderate eczema (atopic dermatitis) in adults and children 2 years of age and older.

See Full Prescribing Information and Patient Information.

For more information call 1-866-EUCRISA (1-866-382-7472)

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.

Copyright © 2019 Pfizer Inc.
All rights reserved.

Pfizer, PO Box 29387, Mission, KS 66201

Last Updated: July 2019
PP-CRI-USA-1238

Pfizer logo
Important Safety Information & Indication
 

IMPORTANT SAFETY INFORMATION

Do not use EUCRISA if you are allergic to crisaborole or any of the ingredients in EUCRISA.

EUCRISA may cause side effects including allergic reactions at or near the application site. These can be serious and may include hives, itching, swelling, and redness. If you have any of these symptoms, stop using EUCRISA and get medical help right away.

The most common side effect of EUCRISA is application site pain, such as burning or stinging.

EUCRISA is for use on skin (topical use) only. Do not use EUCRISA in your eyes, mouth, or vagina.

INDICATION
EUCRISA is a prescription ointment used on the skin (topical) to treat mild-to-moderate eczema (atopic dermatitis) in adults and children 2 years of age and older.

See Full Prescribing Information .